The Cooper Companies Sees Unusually Large Options Volume (NYSE:COO)

The Cooper Companies, Inc. (NYSE:COO) saw unusually large options trading on Thursday. Investors purchased 3,267 call options on the company. This is an increase of 1,892% compared to the average daily volume of 164 call options.

In other The Cooper Companies news, CFO Brian G. Andrews sold 4,963 shares of The Cooper Companies stock in a transaction dated Tuesday, September 7th. The stock was sold at an average price of $453.12, for a total transaction of $2,248,834.56. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Gary S. Petersmeyer sold 1,800 shares of The Cooper Companies stock in a transaction dated Wednesday, September 15th. The stock was sold at an average price of $440.73, for a total value of $793,314.00. The disclosure for this sale can be found here. Insiders have sold a total of 84,287 shares of company stock valued at $37,722,232 over the last ninety days. 1.70% of the stock is owned by company insiders.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Parametric Portfolio Associates LLC boosted its stake in shares of The Cooper Companies by 4.2% during the 2nd quarter. Parametric Portfolio Associates LLC now owns 130,944 shares of the medical device company’s stock worth $51,889,000 after acquiring an additional 5,267 shares in the last quarter. B. Metzler seel. Sohn & Co. Holding AG boosted its stake in shares of The Cooper Companies by 4.4% during the 2nd quarter. B. Metzler seel. Sohn & Co. Holding AG now owns 688 shares of the medical device company’s stock worth $273,000 after acquiring an additional 29 shares in the last quarter. Marshall Wace LLP boosted its stake in shares of The Cooper Companies by 122.6% during the 2nd quarter. Marshall Wace LLP now owns 53,030 shares of the medical device company’s stock worth $21,014,000 after acquiring an additional 29,208 shares in the last quarter. Thrivent Financial for Lutherans boosted its stake in shares of The Cooper Companies by 388.6% during the 2nd quarter. Thrivent Financial for Lutherans now owns 44,065 shares of the medical device company’s stock worth $17,461,000 after acquiring an additional 35,047 shares in the last quarter. Finally, Bradley Foster & Sargent Inc. CT boosted its stake in shares of The Cooper Companies by 38.9% during the 2nd quarter. Bradley Foster & Sargent Inc. CT now owns 10,829 shares of the medical device company’s stock worth $4,291,000 after acquiring an additional 3,031 shares in the last quarter. Institutional investors own 97.08% of the company’s stock.

NYSE COO opened at $439.34 on Friday. The company has a current ratio of 1.39, a quick ratio of 0.83 and a debt-to-equity ratio of 0.17. The business’s 50 day moving average is $431.04 and its two-hundred day moving average is $405.54. The Cooper Companies has a 12-month low of $314.29 and a 12-month high of $463.59. The stock has a market capitalization of $21.66 billion, a price-to-earnings ratio of 7.49, a PEG ratio of 3.39 and a beta of 0.83.

The Cooper Companies (NYSE:COO) last released its earnings results on Wednesday, September 1st. The medical device company reported $3.41 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $3.29 by $0.12. The Cooper Companies had a return on equity of 11.42% and a net margin of 102.48%. The company had revenue of $763.40 million for the quarter, compared to analysts’ expectations of $727.30 million. During the same quarter in the previous year, the firm posted $2.28 EPS. The firm’s quarterly revenue was up 32.0% on a year-over-year basis. Equities analysts forecast that The Cooper Companies will post 13.32 earnings per share for the current fiscal year.

The firm also recently announced a Semi-Annual dividend, which was paid on Wednesday, August 11th. Shareholders of record on Tuesday, July 27th were given a dividend of $0.03 per share. The ex-dividend date of this dividend was Monday, July 26th. The Cooper Companies’s payout ratio is 0.62%.

COO has been the topic of a number of research analyst reports. Stifel Nicolaus lifted their target price on The Cooper Companies from $450.00 to $475.00 and gave the stock a “buy” rating in a research report on Friday, September 3rd. Robert W. Baird reiterated a “hold” rating and set a $423.00 target price on shares of The Cooper Companies in a research report on Friday, September 3rd. Citigroup lifted their target price on The Cooper Companies from $400.00 to $453.00 and gave the stock a “neutral” rating in a research report on Friday, September 3rd. Stephens lifted their target price on The Cooper Companies from $430.00 to $450.00 and gave the stock an “overweight” rating in a research report on Friday, July 16th. Finally, Wells Fargo & Company boosted their price target on The Cooper Companies from $445.00 to $480.00 and gave the company an “overweight” rating in a research report on Thursday, August 19th. Two equities research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Buy” and a consensus target price of $433.08.

About The Cooper Companies

The Cooper Cos, Inc operates as a medical device company. It operates through the Cooper Vision and Cooper Surgical segments. The Cooper Vision segment develops, manufactures, and markets products for contact lens wearers, which solves vision challenges such as astigmatism, presbyopia, myopia, ocular dryness, and eye fatigues.

Featured Article: What is the Gross Domestic Product (GDP)?

Receive News & Ratings for The Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.